Aracari Biosciences Inc.

Drug discovery remains an expensive and time-consuming process. Promising compounds proceed through clinical trials only to have many fail before FDA approval. Aracari Biosciences aims to simplify this process by more accurately and efficiently evaluating promising drug compounds in a human tissue-on-a-chip model prior to clinical trials. Our proprietary, Vascularized Micro-Organ (VMO) platform is the first to contain a 3D, perfused network of living, dynamic human blood vessels that deliver nutrients and drugs directly to tissues just as in the body. Ask about our oncology models that incorporate multiple human tumor types within the vascularized tissue or our blood-brain barrier model for testing trans-barrier transport of drug compounds targeting the brain.

网站

https://www.aracaribio.com

Aracari Biosciences Inc.的外部链接

所属行业

生物技术

规模

2-10 人

总部

Irvine，CA

类型

私人持股

创立

2019

领域

biotechnology、Drug Development、Oncology、Immuno-oncology、Blood-Brain Barrier、Organ-on-a-Chip和Drug Discovery